Monterey Bio Acquisition ...

NASDAQ: MTRYU · Real-Time Price · USD
10.41
-0.54 (-4.93%)
At close: Sep 08, 2023, 3:39 PM

Company Description

Monterey Bio Acquisition Corporation does not have significant operations.

It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry.

The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021.

Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.

Monterey Bio Acquisition Corporation
Monterey Bio Acquisition Corporation logo
Country United States
IPO Date Oct 1, 2021
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO Murat Omur

Contact Details

Address:
17 State Street
New York City, New York
United States
Website https://www.montereybio.com

Stock Details

Ticker Symbol MTRYU
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001860663
CUSIP Number 61240F207
ISIN Number US61240F2074
Employer ID 85-2204842
SIC Code 6770

Key Executives

Name Position
Dr. Sanjeev Satyal Ph.D. Chief Executive Officer
Murat Omur Chief Executive Officer
Sean McGann Chief Financial Officer
William McKeever Chief Financial Officer & Director
Jonas Sven Magnus Grossman M.B.A. Executive Chairman

Latest SEC Filings

Date Type Title
Sep 30, 2022 8-K Current Report
Sep 08, 2022 DEF 14A Filing
Aug 24, 2022 PRE 14A Filing
Aug 11, 2022 10-Q Quarterly Report
May 13, 2022 10-Q Quarterly Report
Mar 29, 2022 10-K Annual Report
Feb 14, 2022 SC 13G Statement of acquisition of beneficial ownership b...
Feb 14, 2022 SC 13G Statement of acquisition of beneficial ownership b...
Feb 14, 2022 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 07, 2022 SC 13G/A [Amend] Statement of acquisition of beneficial own...